We reported previously (Cayabyab, F. S., and Schlichter, L. C. (2002) J. Biol. Chem. 277, 13673-13681) a functional interaction between the ERG-1 K ؉ channel and Src tyrosine kinase, which increased the current. We now show that the tyrosine phosphatase, SHP-1, which is present in microglia, is increased after brain damage, and is activated by colony-stimulating factor-1, associates with ERG-1 and regulates the current. Patch clamp recordings from the MLS-9 microglia cells were made with pipette solutions containing a recombinant SHP-1 protein: wild type (SHP-1 wild type (wt)), catalytically active (SHP-1 S6), or the substrate-trapping mutant (SHP-1 Cys 3 Ser). SHP-1 wt and SHP-1 S6 proteins decreased the current, an effect that was reversed by the phosphatase inhibitor, pervanadate, whereas SHP-1 Cys 3 Ser increased the current. Moreover, transient transfection with cDNA for SHP-1 wt or SHP-1 S6 decreased the ERG current without decreasing the protein level. Tyrosine phosphorylation of ERG-1 was decreased by transfection with SHP-1 wt and increased by SHP-1 Cys 3 Ser. The decrease in current by active SHP-1 was partly attributed to changes in the voltage dependence of activation and steady-state conductance, whereas inactivation kinetics and voltage dependence were not affected. Our results show that ERG-1 is a SHP-1 substrate constituting the first report that an ion current is regulated by SHP-1.
In excitable cells, Kϩ channels set the membrane potential (V m ), which is crucial for regulating excitability, Ca 2ϩ influx, and secretion. Their roles in non-excitable cells may be even more diverse. In addition to controlling V m and Ca 2ϩ entry, K ϩ channels contribute to ion homeostasis, cell cycle, proliferation, differentiation, apoptosis, and to cell volume regulation, which counteracts metabolically generated osmolytes. The human ether-à -go-go-related gene (HERG) 1 was originally thought to be heart-specific, where its natural mutations underlie one type of life-threatening arrhythmia (2-4). However, HERG and ether-à -go-go K ϩ channels are expressed in certain cancers, leading to intense interest in their contributions to proliferation and cell survival (5, 6). We recently provided the first direct evidence of a functional role for HERG in cancer cells (7). HERG was selectively up-regulated in primary leukemias and several hematopoietic cell lines, and the HERG-channel blocker, E-4031, reduced proliferation in some of the cell lines. HERG and the three known rat ERG isoforms are expressed in the nervous system, and although ERG-2 was thought to be restricted to a small subpopulation of neurons (8), we found ERG-2 mRNA in rat microglia (1). ERG channels in neurons can modulate the resting potential (9), spike frequency (10), hormonal secretion (11, 12), and neuritogenesis (9, 13), although some roles have only been studied in cell lines. We previously identified ERG currents and ERG-1 protein in the brain microglia cell line (MLS-9) that we developed (1, 14, 15). Because MLS-9 cells lack the Kv1.3 and clas...